Your browser doesn't support javascript.
loading
Hepatocellular carcinoma after a sustained virological response by direct-acting antivirals harbors TP53 inactivation.
Imamura, Taisuke; Okamura, Yukiyasu; Ohshima, Keiichi; Uesaka, Katsuhiko; Sugiura, Teiichi; Ito, Takaaki; Yamamoto, Yusuke; Ashida, Ryo; Ohgi, Katsuhisa; Otsuka, Shimpei; Ohnami, Sumiko; Nagashima, Takeshi; Hatakeyama, Keiichi; Kakuda, Yuko; Sugino, Takashi; Urakami, Kenichi; Akiyama, Yasuto; Yamaguchi, Ken.
Affiliation
  • Imamura T; Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
  • Okamura Y; Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
  • Ohshima K; Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan.
  • Uesaka K; Medical Genetics Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.
  • Sugiura T; Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
  • Ito T; Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
  • Yamamoto Y; Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
  • Ashida R; Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
  • Ohgi K; Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
  • Otsuka S; Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
  • Ohnami S; Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
  • Nagashima T; Cancer Diagnostics Research Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.
  • Hatakeyama K; Cancer Diagnostics Research Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.
  • Kakuda Y; SRL, Inc., Tokyo, Japan.
  • Sugino T; Medical Genetics Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.
  • Urakami K; Division of Pathology, Shizuoka Cancer Center, Shizuoka, Japan.
  • Akiyama Y; Division of Pathology, Shizuoka Cancer Center, Shizuoka, Japan.
  • Yamaguchi K; Cancer Diagnostics Research Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.
Cancer Med ; 11(8): 1769-1786, 2022 04.
Article in En | MEDLINE | ID: mdl-35174643
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis C / Carcinoma, Hepatocellular / Hepatitis C, Chronic / Liver Neoplasms Limits: Humans Language: En Journal: Cancer Med Year: 2022 Document type: Article Affiliation country: Japan
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis C / Carcinoma, Hepatocellular / Hepatitis C, Chronic / Liver Neoplasms Limits: Humans Language: En Journal: Cancer Med Year: 2022 Document type: Article Affiliation country: Japan